Success Story: EB-2 NIW Approval for a Hematology Oncology Expert Enhancing Cancer Survivorship Care

Posted by wegreened on July 27, 2026 in NIW, Medicine (Pharmaceutics, Pharmacology, Oncology, Pharmacognosy, Biomedical Engineering, Biomedicine)

On March 4^th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for an Assistant Professor in the Field of Hematology Oncology (Approval Notice).

General Field: Hematology Oncology

Position at the Time of Case Filing: Assistant Professor

Country of Origin: India

State of Residence at the Time of Filing: Texas

Approval Notice Date: March 4^th, 2026

Processing Time: 19 months, 2 days (Premium Processing Upgrade Requested)

Case Summary:

We are thrilled to announce that North America Immigration Law Group (Chen Immigration Law Associates) has successfully secured an EB-2 National Interest Waiver (NIW) approval for a highly accomplished physician and researcher in the field of hematology oncology.

Transforming Post-Treatment Care and Survivorship

Holding an M.B.B.S. degree, our client has dedicated her career to addressing a critical gap in long-term oncology care. Her work focuses on developing predictive tools specifically designed to identify the adverse effects of various cancer treatments in cancer survivors.

By anticipating these complications, her research aims to dramatically improve health outcomes and the quality of life for cancer survivors. Furthermore, these tools provide healthcare professionals with targeted and highly effective strategies for managing and preventing severe treatment-related complications down the line.

A Robust and Diversified Scholarly Portfolio

We meticulously outlined her extensive publication record. Her clinical research has resulted in a highly diversified portfolio, including:

20 peer-reviewed journal articles (including 1 first-authored paper)

6 peer-reviewed conference papers (including 2 first-authored papers)

6 book chapters

Because her methodologies address pressing challenges in clinical medicine, her publications have been relied upon by her peers globally, accumulating a total of 105 citations. Moreover, her standing as a trusted authority in hematology oncology is evidenced by her role as a peer reviewer, having completed at least 6 reviews to date for relevant academic journals.

Expert Validation of Clinical Frameworks

A cornerstone of our legal strategy was demonstrating the real-world, clinical implementation of her findings. To do this, we incorporated independent expert testimonies that validated the national importance of her original contributions.

Highlighting her work on severe thoracic complications, one recommender stated:

"Through her comprehensive research, [Client] provided a framework for clinicians to optimize patient care during and after thoracic radiotherapy by enhancing their understanding of radiation-induced lung injury (RILI)'s epidemiology, pathophysiology, risk factors, and management strategies."

Through a careful presentation of her academic training, strong publication record, and the national importance of improving cancer survivorship care, we successfully showed that waiving the labor certification requirement would serve the interests of the United States.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%